Effective revascularization of the patient with peripheral artery disease is about more than
the procedure. The approach to the patient with symptom-limiting intermittent claudication or …

Peripheral arterial disease (PAD) continues to grow in global prevalence and consumes an
increasing amount of resources in the United States health care system. Overall rates of …

Guideline Summary Chronic limb-threatening ischemia (CLTI) is associated with mortality,
amputation, and impaired quality of life. These Global Vascular Guidelines (GVG) are …

Patients with widespread atherosclerosis such as peripheral artery disease (PAD) have a
high risk of cardiovascular and limb symptoms and complications, which affects their quality …

Critical limb ischemia (CLI) is considered the most severe pattern of peripheral artery
disease. It is defined by the presence of chronic ischemic rest pain, ulceration or gangrene …

Advances in endovascular therapies during the past decade have broadened the options for
treating peripheral vascular disease percutaneously. Endovascular treatment offers a lower …

Background: Drug-eluting balloons (DEB) may reduce infrapopliteal restenosis and
reintervention rates versus percutaneous transluminal angioplasty (PTA) and improve …

Background—The 1-year restenosis rate after balloon angioplasty of long lesions in below-
the-knee arteries may be as high as 70%. Our aim was to investigate the efficacy of a …

Objectives: The purpose of this study was to investigate the efficacy of drug-eluting balloons
(DEBs) in the treatment of long infrapopliteal lesions with regard to the short-term restenosis …

Background—Contemporary outcomes of percutaneous transluminal angioplasty for the
treatment of infrapopliteal atherosclerotic lesions are not well characterized. Hence, a …